Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > In vivo distribution of 125I-radiolabelled solid lipid nanoparticles
Publication

Publications

In vivo distribution of 125I-radiolabelled solid lipid nanoparticles

Title
In vivo distribution of 125I-radiolabelled solid lipid nanoparticles
Type
Article in International Scientific Journal
Year
2006
Authors
Weyhers, H
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Lobenberg, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Mehnert, W
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Souto, EB
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Kreuter, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Muller, RH
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
The Journal is awaiting validation by the Administrative Services.
Vol. 68
Pages: 889-894
ISSN: 0031-711X
Indexing
Other information
Authenticus ID: P-00F-SJ1
Abstract (EN): Biodegradable surface-modified solid lipid nanoparticles (SLN) were radiolabelled by incorporation of a lipophilic radiochemical (testosterone 125I-labelled histamine derivative) into the lipid matrix. The radiolabelled SLN dispersions were intravenously injected via the tail vein of Wistar Unilever rats. The subsequent organ distribution was determined at 5 different time points (5 min, 15 min, 1 h, 4 h, 24 h) by the quantification of radioactivity in the dissected organs. The organ distribution pattern of the administered SLN batches showed no relevant differences to the aqueous solution of the marker (reference). In vitro release studies in plasma proved at least for the first time point (5 min) a satisfying stability of the radioactive labelling. For this time point, the observed data indicated that the administered SLN formulations remain in the blood in contrast to many other colloidal drug carriers. Otherwise significant higher amounts of radioactivity would have been determined in organs of the mononuclear phagocytic system (MPS) such as liver and spleen, in comparison to the organ distribution of the reference (aqueous solution of free marker). The body distribution of circulating SLN that rapidly release the marker is in general similar to the administered reference at later time points after the injection. The identical organ distribution at times higher than 15 min was attributed to degradation of SLN leading to a fast release of the marker. © ECV · Editio Cantor Verlag.
Language: English
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

In vivo distribution of I-125-radiolabelled solid lipid nanoparticles (2006)
Article in International Scientific Journal
Weyhers, H; Loebenberg, R; Mehnert, W; Souto, EB; Kreuter, J; Mueller, RH
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-18 at 21:24:32 | Privacy Policy | Personal Data Protection Policy | Whistleblowing